BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7602375)

  • 61. Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.
    Champlin R; Gajewski J; Nimer S; Vollset S; Landaw E; Winston D; Schiller G; Ho W
    J Clin Oncol; 1990 Jul; 8(7):1199-206. PubMed ID: 1694236
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
    Krug U; Röllig C; Koschmieder A; Heinecke A; Sauerland MC; Schaich M; Thiede C; Kramer M; Braess J; Spiekermann K; Haferlach T; Haferlach C; Koschmieder S; Rohde C; Serve H; Wörmann B; Hiddemann W; Ehninger G; Berdel WE; Büchner T; Müller-Tidow C; ;
    Lancet; 2010 Dec; 376(9757):2000-8. PubMed ID: 21131036
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term follow-up of a randomized post-induction therapy trial in acute myelogenous leukemia (a Southeastern Cancer Study Group trial).
    Volger WR; Weiner RS; Moore JO; Omura GA; Bartolucci AA; Stagg M
    Leukemia; 1995 Sep; 9(9):1456-60. PubMed ID: 7544851
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Progress in acute myelogenous leukemia.
    Gale RP
    Cancer Treat Rep; 1981; 65 Suppl 4():87-92. PubMed ID: 7049383
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of acute myelogenous leukemia in the elderly.
    Champlin RE; Gajewski JL; Golde DW
    Semin Oncol; 1989 Feb; 16(1):51-6. PubMed ID: 2645650
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Acute myelogenous leukemia in elderly].
    Mori M
    Rinsho Ketsueki; 1999 Feb; 40(2):77-80. PubMed ID: 10199195
    [No Abstract]   [Full Text] [Related]  

  • 67. Are we curing acute myelogenous leukemia?
    Ben-Bassat I; Bandini G; Rosti G; Gale RP
    Leuk Res; 1993 Dec; 17(12):1071-2. PubMed ID: 8246611
    [No Abstract]   [Full Text] [Related]  

  • 68. Dose-intensive treatment of acute myelogenous leukemia: improved survival?
    Schiller G
    J Clin Oncol; 1995 Jul; 13(7):1828-30. PubMed ID: 7602375
    [No Abstract]   [Full Text] [Related]  

  • 69. Chemotherapy in acute myelogenous leukemia: high dose, higher expectations?
    Berman E
    J Clin Oncol; 1995 Jan; 13(1):1-4. PubMed ID: 7799008
    [No Abstract]   [Full Text] [Related]  

  • 70. [Acute myelogenous leukemia in elderly patients].
    Mori M
    Nihon Ronen Igakkai Zasshi; 2000 Mar; 37(3):192-6. PubMed ID: 10879065
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.